Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer
Authors:
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancerInternational Journal of Cancer, 2017
- Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancerNature Communications, 2017
- The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer PatientsInternational Journal of Molecular Sciences, 2017
- Performance status and neutrophil-lymphocyte ratio are important prognostic factors in elderly patients with unresectable pancreatic cancerJournal of Gastrointestinal Oncology, 2016
- Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinomaOncoImmunology, 2016
- Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancerSurgery Today, 2016
- Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancerClinical Science, 2016
- Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinibWorld Journal of Gastrointestinal Oncology, 2016
- Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratiosSurgery Today, 2015
- Elevated pre-operative neutrophil to lymphocyte ratio predicts disease free survival following pancreatic resection for periampullary carcinomasPancreatology, 2013